TARGET GPS Trademark

Trademark Overview

On Friday, October 6, 2023, a trademark application was filed for TARGET GPS with the United States Patent and Trademark Office. The USPTO has given the TARGET GPS trademark a serial number of 98212704. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 3, 2025. This trademark is owned by Superluminal Medicines, Inc.. The TARGET GPS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations and medicines
target gps

General Information

Serial Number98212704
Word MarkTARGET GPS
Filing DateFriday, October 6, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, June 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 3, 2025

Trademark Statements

Goods and ServicesDevelopment of pharmaceutical preparations and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, October 14, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSuperluminal Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02116
Party NameSuperluminal Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02116

Trademark Events

Event DateEvent Description
Saturday, October 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 3, 2024NON-FINAL ACTION E-MAILED
Tuesday, October 10, 2023NEW APPLICATION ENTERED
Tuesday, May 28, 2024ASSIGNED TO EXAMINER
Monday, June 3, 2024NON-FINAL ACTION WRITTEN
Monday, June 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2024NON-FINAL ACTION E-MAILED
Wednesday, October 2, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 27, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, April 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 27, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, May 1, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 28, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 3, 2025PUBLISHED FOR OPPOSITION
Tuesday, June 3, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

target medicines preparations pharmaceutical development